Assessment of risks related to medicine dispensing by nonprofessionals in Colombia: Clinical case simulations

Annals of Pharmacotherapy

Volumn 39, Issue 3, 2005, Pages 527-532

  Vacca, Claudia ^a   Orozco, José ^b   Figueras, Albert ^c,d   Capellà, Dolors ^c,d  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c Fundacion Institut Catala de Farmacologia   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Continuing education; Dispensing; Drug utilization; Rational drug use; Simulation

Indexed keywords

ARTICLE; COLOMBIA; DRUG MARKETING; DRUG USE; DRUG UTILIZATION; INTERVIEW; PHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION;

ADULT; CLINICAL COMPETENCE; COLOMBIA; CROSS-SECTIONAL STUDIES; EDUCATION, CONTINUING; EDUCATIONAL STATUS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; PATIENT SIMULATION; PHARMACEUTICAL SERVICES; RISK ASSESSMENT;

EID: 13944250190     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E420     Document Type: Article

References (14)

1. Ensuring good dispensing practices. In: Managing drug supply. Bloomfield, CT: Kumarian Press, 1997:483-95.
2. Fourth WHO Consultative Group on the Role of Pharmacists. The role of the pharmacist in self-care and self-medication. WHO/DAP 98.13. Geneva: World Health Organization, 1998. www.who.int/medicines/library/ dap/who-dap-98-13/who- dap-98-13.pdf (accessed 2004 Sept 17).
3. Third WHO Consultative Group on the Role of the Pharmacist. The role of the pharmacist in the health care system. WHO/PHARM/97/959. Geneva: World Health Organization, 1997. http://whqlibdoc.who.int/hq/ 1997/WHO_PHARM_97_599.pdf (accessed 2004 Sept 17).
4. Youmans SL, Schillinger D. Functional health literacy and medication use: the pharmacist's role. Ann Pharmacother 2003;37:1726-9. DOI 10.1345/aph.1D070
5. Lamsam GD, Kropff MA. Community pharmacists' assessments and recommendations for treatment in four case scenarios. Ann Pharmacother 1998;32:409-16. DOI 10.1345/aph.17287
6. Rutter PM, Horsley E, Brown DT. Evaluation of community pharmacists' recommendations to standarized patient scenarios. Ann Pharmacother 2004;38:1080-5. DOI 10.1345/aph.1D519
7. Perfil Farmacoterapéutico del Mercado Privado de Medicamentos en Colombia (Datos IMS. World Pharma Market). OPS Bogotá, 2001.
8. Vacca C, Holguín E, Orozco J. Equidad en el acceso y la calidad de la terapia farmacológica en el marco de la Ley 100. OPS, 2002.
9. Moya O, Vacca C. Evaluación de la recomendación de antibióticos en IRA y EDA en menores de edad. Secretaría de Salud de Bogotá. XXIII National Conference of Pharmacists, Bogotá, 1997.
10. Figueras A, Laporte JR. Failures of the therapeutic chain as a case of drug ineffectiveness (editorial). BMJ 2003;326:895-6.
11. Drug-company influence on medical education in USA (editorial). Lancet 2000;356:781.
12. Dennis R, Lozano JM. Ethical challenges in pharmacoepidemiological research in Colombia. Pharmacoepidemiol Drug Saf 2001;10:613-8.
13. Allan E, Barker K, Malloy M, Heller W. Dispensing errors and counseling in community practice. Am Pharm 1995;NS35:25-33.
14. Barros JAC. A atuação dos balconistas de farmácia: ajudando a promover o uso racional dos medicamentos? Jornal Bras Med 1997;73:120-8.